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AKT Delays the Early-Activated Apoptotic Pathway in
UVB-Irradiated Keratinocytes Via BAD Translocation
Sofie Claerhout1, David Decraene1, An Van Laethem1,2, Sofie Van Kelst1,2,3, Patrizia Agostinis2 and
Marjan Garmyn1
Upon irradiation with a high dose of UVB, keratinocytes undergo apoptosis as a protective mechanism.
In previous work, we demonstrated the existence of an early-activated UVB-induced apoptotic pathway in
growth factor-depleted human keratinocytes, which can be substantially delayed by the exclusive
supplementation of IGF-1. We now show that in human keratinocytes, IGF-1 inhibits the onset of
UVB-triggered apoptosis through a transcriptional independent, AKT-mediated mechanism, involving BAD
serine 136 phosphorylation. Our results show that the early UVB-induced apoptosis in growth factor-depleted
human keratinocytes is exclusively triggered through the mitochondrial pathway. It is accompanied by BAX
translocation, cytochrome c release, and procaspase-9 cleavage, but not by procaspase-8 or BID cleavage. In
human keratinocytes, IGF-1 supplementation inhibits these events in a transcription-independent manner.
Both IGF-1 supplementation and the transduction of a membrane-targeted form of AKT result in a shift of the
BH3-only protein BAD from the mitochondria to the cytoplasm, paralleled by an increase of AKT-specific Ser136
phospho-BAD bound to 14-3-3z protein. These data indicate that AKT-induced BAD phosphorylation and its
subsequent cytoplasmic sequestration by 14-3-3z is a major mechanism responsible for the postponement of
UVB-induced apoptosis in human keratinocytes.
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INTRODUCTION
Chronic exposure to solar UVB is associated with the onset of
various pathological conditions, including skin cancer
(Henriksen et al., 1990). To cope with the adverse effects of
solar UVB, keratinocytes have developed a typical UVB
response. The outcome of this response depends highly on
the amount of DNA damage induced by UVB irradiation. At
low UVB doses, keratinocytes induce a temporary cell cycle
arrest, during which they repair photolesions through a
process called nucleotide excision repair. With increasing
UVB-induced damage, the nucleotide excision repair process
will ultimately fail, jeopardizing the genomic integrity of the
affected cell and its future replicates. Replication of damaged
DNA leads to an error-prone incorporation of nucleotides at
the site of a photolesion, increasing the risk of malignant
transformation. Healthy keratinocytes possess a fail-safe
mechanism against copious amounts of DNA damage: the
formation of sunburn cells, representing keratinocytes under-
going apoptosis (Van Laethem et al., 2005; Claerhout et al.,
2006). It is well established that the caspases are central
executioners of the apoptotic pathway triggered by UVB
exposure in human keratinocytes (Assefa et al., 2005; Van
Laethem et al., 2005; Claerhout et al., 2006). Two main
routes of caspase-dependent cell death have been defined.
The so-called ‘‘extrinsic pathway’’ is triggered by death
receptor-mediated stimuli and results in the recruitment and
activation of procaspase-8/-10 at the death-inducing signal-
ing complex. Caspase-8 and -10, in turn, promote activation
of downstream effector procaspase-3, -6, and -7. The
‘‘intrinsic pathway’’ is triggered by a diverse array of cellular
stress utilizing mitochondria as major control point. The
hallmark of this pathway is the release of cytochrome c into
the cytosol and the subsequent activation of procaspase-9,
through the formation of the ‘‘apoptosome’’ (Danial and
Korsmeyer, 2004). Caspase-9 then cleaves and activates
effector caspases. Crosstalk between the death receptor and
the mitochondrial pathway is provided by the BCL-2 family
member and BH3-only protein, BID. UV-induced cell death
has been proposed to involve three processes contributing
independently to the activation of the intrinsic and the
extrinsic apoptotic pathway; these three processes are DNA
damage, membrane receptor clustering, and formation of
reactive oxygen species (Kulms and Schwarz, 2002). Recent
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studies, however, indicate that irradiating keratinocytes with
physiologic relevant UVB doses induces apoptosis mainly
through the intrinsic pathway (Assefa et al., 2005; Van
Laethem et al., 2005; Claerhout et al., 2006). Circumventing
the apoptotic program is an acquired trait of many tumor cells
(Jaattela, 1999). Therefore, a better understanding of the
molecular mechanisms of UVB-induced apoptosis is a prime
concern in the development of effective therapeutic strategies
against skin photocarcinogenesis.
A signaling pathway that is known to intervene in the
crucial decision of survival versus programmed cell death in
skin is the IGF-1/AKT signaling pathway. It is therefore no
surprise that the IGF-1/AKT signaling pathway is also
documented as one of the key elements in the multistep
development of skin cancer in mice (DiGiovanni et al., 2000;
Segrelles et al., 2002). The protooncogene c-akt, a serine
(Ser)-threonine (Thr) protein kinase, is the cellular homolog of
the viral oncogene v-akt (Bellacosa et al., 1991). AKT, also
known as protein kinase B, is catalytically activated by
phosphorylation at Thr308 and Ser473 (Alessi et al., 1996).
IGF-1, a major survival factor for a variety of cell types, is a
potent activator of the AKT signaling pathway (Dudek et al.,
1997; Kulik et al., 1997; Leri et al., 1999; Remacle-Bonnet
et al., 2000). Many new downstream targets of AKT have
been identified, which can promote proliferation by facilitat-
ing cell cycle progression (Brennan et al., 1997; Muise-
Helmericks et al., 1998; Zhou et al., 2001; Okumura et al.,
2002), or can promote survival either by transcription-
dependent or transcription-independent means (Datta et al.,
1997; Brunet et al., 1999; Kops et al., 1999; Ozes et al.,
1999; Zheng et al., 2000; Kim et al., 2001; Kim et al., 2002).
In previous work, we have demonstrated that IGF-1 can
delay the apoptotic response of normal human keratinocytes
to UVB damage (Decraene et al., 2002). This delay is
paralleled by AKT phosphorylation indicative of AKT activa-
tion. In addition, it allows more time for DNA repair and
increases the threshold for UVB-induced apoptosis (Decraene
et al., 2002). We also demonstrated that in malignant
keratinocytes, the early-activated apoptotic response to
UVB is deregulated, concomitant with an altered phosphory-
lation status of AKT in these malignant cells (Decraene et al.,
2004). The aim of this study was to identify the molecular
mechanism by which IGF-1 is able to postpone early UVB-
induced apoptosis in normal keratinocytes. Our first aim was
to identify the molecular base of early-induced apoptosis in
UVB-irradiated keratinocytes, grown in growth factor-
depleted medium. Secondly, we investigated the direct
involvement of AKT in this process as IGF-1 is a potent activator
of AKT. Finally, we investigated which molecular target of AKT
was responsible for the delay of UVB-induced apoptosis.
RESULTS
The early-activated UVB-induced apoptosis is triggered by the
mitochondrial pathway
Human keratinocytes, grown in the absence of growth
factors, undergo apoptosis as soon as 3 hours after UVB
irradiation. We have recently shown that this early induction
of apoptosis can be specifically inhibited by IGF-1 and
postponed to a later time point (Decraene et al., 2002).
To identify the mechanism responsible for the early-
activated, UVB-induced apoptotic pathway, we first exam-
ined the release of mitochondrial cytochrome c into the
cytosol, a hallmark of intrinsic pathway-mediated apoptosis.
When irradiated with an apoptosis-inducing UVB dose
(100 mJ/cm2), growth factor-deprived keratinocytes displayed
increased cytochrome c levels in the cytoplasmic fraction as
early as 1.5 hours after UVB irradiation. A corresponding
decrease in mitochondrial cytochrome c levels was observed
as early as 3 hours after UVB irradiation (Figure 1a). The
addition of 10 ng/ml IGF-1 before UVB irradiation inhibited
the mitochondrial release of cytochrome c (Figure 1a).
Cytochrome c release in the early-activated apoptotic path-
way was further confirmed by immunostaining primary
keratinocytes for cytochrome c 3 hours after UVB irradiation.
In comparison to IGF-1-pretreated cells, more growth factor-
deprived cells exhibited, 3 hours after an apoptotic UVB dose
(100 mJ/cm2), a diffuse, homogeneous staining pattern (Figure
1c), indicative of the release of cytochrome c into the cytosol.
The cytosolic localization of cytochrome c was confirmed by
staining the mitochondria with MitoTrackerRed, a mitochon-
drion-selective dye (Figure 1b and d). In contrast, IGF-1-
pretreated cells displayed a perinuclear, mitochondrial
staining pattern for cytochrome c (Figure 1f), which co-
localized with the signal obtained by MitoTrackerRed (Figure
1e and g). No dispersion of cytochrome c could be observed
in these cells (Figure 1f).
Another biochemical characteristic of the intrinsic apop-
tosis pathway is the translocation of proapoptotic BCL-2
family member BAX from the cytosol to the mitochondria
(Capano and Crompton, 2002). Three hours after irradiation
(100 mJ/cm2 UVB), keratinocytes were immunostained with
an antibody directed against the N-terminal end of BAX. In
growth factor-deprived cells, a BAX perinuclear staining
pattern could be observed (Figure 1i), indicating that BAX
was in its active conformation and that translocation to the
mitochondria had occurred. Co-localization of BAX with
MitoTrackerRed (Figure 1h and j) confirmed a translocation
of BAX from the cytosol to the mitochondria. In contrast, no
active BAX could be observed in IGF-1-pretreated cells at this
time point (Figure 1l). Immunocytochemical staining with the
signal obtained by MitoTrackerRed confirmed that no
translocation of BAX to the mitochondria had occurred
(Figure 1k and m).
To further confirm the involvement of the intrinsic
pathway in the early induction of apoptosis after UVB, we
investigated procaspase-9 and -8 cleavage. As soon as
3 hours after irradiation, a larger decrease of the intact
procaspase-9 form can be observed in growth factor-deprived
cells in comparison to IGF-1- (10 ng/ml) pretreated cells
(Figure 2). During this time period, no processing of
procaspase-8 could be observed, neither in growth factor-
deprived cells nor in IGF-1-pretreated cells (Figure 2). In
addition, no BID processing could be observed in the first
6 hours after UVB irradiation (Figure 2), thus excluding a
possible involvement of the death receptor-mediated path-
way of apoptosis in the early release of cytochrome c.
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Early UVB-induced apoptosis and its inhibition by IGF-1 occur
independent of new protein synthesis
To determine whether new protein synthesis is required
either in the induction of the early-activated apoptosis or in
the delay of early-activated apoptosis by IGF-1 supplementa-
tion, cells were pretreated for 1 hour with 10mg/ml cyclo-
heximide, a potent inhibitor of protein translation. As
demonstrated previously (Decraene et al., 2002), the
monitoring of the time course for caspase-3-induced cleavage
of poly-ADP ribose polymerase (PARP) is a convenient
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Figure 1. Early-activated and UVB-induced apoptosis is preceded by cytochrome c release and BAX translocation. (a) Growth factor-deprived primary human
keratinocytes were irradiated with 100 mJ/cm2 UVB. At the indicated time points, mitochondrial and cytosolic fractions were isolated by subcellular
fractionation. Proteins were separated by SDS–PAGE and analyzed by immunoblotting with anticytochrome c. IGF-1 (10 ng/ml) was added 30 minutes before
UVB irradiation. (b–d) Growth factor-deprived primary human keratinocytes were irradiated with 100 mJ/cm2 UVB. Three hours after irradiation, cells were
immunostained for cytochrome c. (c) Arrows show cells exhibiting a diffuse, homogeneous staining pattern indicative for cytosolic cytochrome c distribution
and (b and d) MitoTracker overlay shows no co-localization. (e–g) Immunostaining of IGF-1-treated keratinocytes shows a (f) speckled pattern for cytochrome
c and (e and g) MitoTracker overlay confirms the mitochondrial co-localization of cytochrome c. Immunocytochemistry was performed as described in
‘‘Materials and Methods’’. IGF-1 (10 ng/ml) was added 30 minutes before UVB irradiation. (h–j) Growth factor-deprived primary human keratinocytes were
irradiated with 100 mJ/cm2 UVB. Three hours after irradiation, immunostaining for the active conformation of BAX in these keratinocytes shows the
(i) perinuclear-speckled pattern of BAX. (h and j) MitoTracker overlay confirms the mitochondrial co-localization of BAX in these cells. Arrows indicate BAX
translocation. (k–m) Immunocytochemistry of IGF-1-treated keratinocytes shows (l) no active BAX in the cytosol and (k and m) MitoTracker staining of the
mitochondria. Immunocytochemistry was performed as described in ‘‘Materials and Methods’’ IGF-1 (10 ng/ml) was added 30 minutes before UVB irradiation.
www.jidonline.org 431
S Claerhout et al.
AKT Delays the Early Apoptotic UVB Response
biochemical parameter to distinguish between early- versus
late-induced apoptosis in UVB-irradiated keratinocytes.
Growth factor-deprived keratinocytes undergo apoptosis
and display PARP cleavage early after UVB irradiation,
whereas IGF-1-supplemented keratinocytes do not (6 hours
time point, Figure 3a). Instead, induction of apoptosis in IGF-
1-supplemented keratinocytes is postponed to later time
points (24 hours time point, Figure 3a). The addition of
cycloheximide had no effect on either the early induction of
apoptosis by UVB or the delay of the early-activated
apoptosis. This indicates that the early UVB-induced apop-
tosis and the inhibition of apoptosis by IGF-1 occur
independently of new protein synthesis. It is thus unlikely
that transcription factors (like NF-kB) targeted by the IGF-1/
AKT pathway are involved in this process (Figure 3a). In
agreement with this observation, no difference in IkB-a
degradation, indicative of NF-kB activation, could be
observed in the first hours after UVB irradiation, between
the growth factor-depleted and the IGF-1-supplemented cells
(Figure 3b).
AKT postpones early UVB-induced apoptosis through the
cytosolic sequestration of BAD
To study the molecular mechanism involved in the post-
ponement of UVB-induced apoptosis by IGF-1, we investi-
gated the involvement of AKT, as we demonstrated that
IGF-1-mediated delay of the onset of apoptosis is dependent
on phosphorylation of AKT on Ser473 and Thr308 (Decraene
et al., 2002). To assess whether the expression of active AKT
is sufficient to delay the early activation of apoptosis, we
employed an adenoviral vector approach, expressing AKT in
a membrane-targeted form (adenoviral construct expressing
membrane-targeted form of AKT (Ad.myrAKT-HA)) (Matsui
et al., 1999). Ad.myrAKT-HA significantly increases the
expression of the active form of AKT in untreated human
keratinocytes (Figure 4). Growth factor-depleted and UVB-
irradiated keratinocytes, infected with this adenovirus (Ad.-
myrAKT-HA), displayed PARP cleavage at a later time point
(Figure 4) comparable to the IGF-1-supplemented cells (data
not shown; Decraene et al., 2002). In contrast, cells infected
with enhanced green fluorescence protein (EGFP)-expressing
adenovirus, as a control (vector only), remained sensitive to
early apoptosis (Figure 4). Thus, the effect of IGF-1 in the
postponement of early UVB-induced apoptosis can be
completely mimicked by infection of keratinocytes with
myristylated AKT.
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Figure 2. The extrinsic, death receptor-mediated pathway of apoptosis is
not involved in early-activated and UVB-induced apoptosis. Growth
factor-deprived primary human keratinocytes were irradiated with
100 mJ/cm2 UVB. Where indicated, cells were supplemented with IGF-1
(10 ng/ml) 30 minutes before irradiation. Cells were harvested at the
appropriate time points. The proteins were separated by SDS–PAGE and
analyzed for procaspase-8 and -9 and BID by immunoblotting as described
in the ‘‘Materials and Methods’’.
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Figure 3. Neither early-activated apoptosis nor its inhibition by IGF-1
require protein translation. (a) Growth factor-deprived primary human
keratinocytes were irradiated with 100 mJ/cm2 UVB. IGF-1 (10 ng/ml) was
supplemented 30 minutes before irradiation, and CHX (10 mg/ml) was
supplemented 1 hour before irradiation. Cell lysate was collected at the
indicated time points. The proteins were separated by SDS–PAGE and
analyzed by immunoblotting with anti-PARP antiserum. (b) Time course
analysis of IkB-a by Western blot. Growth factor-deprived primary human
keratinocytes were irradiated with 100 mJ/cm2 UVB. IGF-1 (10 ng/ml) was
supplemented 30 minutes before irradiation. Cells were harvested at the
indicated time points as described under ‘‘Materials and Methods’’.
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Figure 4. Early activation of UVB-induced apoptosis can be delayed by
constitutive active AKT by phosphorylating BAD on Ser136. Primary human
keratinocytes were cultured in growth factor-deprived medium and were
transduced either with adenoviral construct expressing EGFP (control
vector) or Ad.myrAKT-HA viruses. Forty-eight hours after transduction, the
keratinocytes were irradiated with 100 mJ/cm2 UVB. Cell lysates were
collected at the indicated time points. The proteins were separated by
SDS–PAGE and blotted with antibodies to PARP, phosphoAKT (Thr308),
total AKT, phospho-BAD (Ser136), and total BAD.
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We next sought to characterize the molecular target
downstream of AKT, which is involved in the delay of UVB-
induced apoptosis. One downstream target of AKT, with a
transcription-independent function in the intrinsic apoptosis
pathway (Yang et al., 1995), is the BH3-only protein BAD.
AKT-mediated phosphorylation of the Ser136 of BAD results
in the relocation of BAD from the mitochondria to the cytosol
(Datta et al., 2000). To determine if the IGF-1/AKT pathway
leads to the phosphorylation of BAD on Ser136 in keratino-
cytes, BAD phosphorylation (Ser136) was investigated in
human keratinocytes infected with Ad.myrAKT-HA versus
control (adenoviral construct expressing EGFP). As expected,
BAD was phosphorylated in cells expressing the membrane-
targeted form of AKT (Figure 4). A possible relocation of BAD
from the mitochondria to the cytosol by IGF-1 was therefore
examined by subcellular fractionation of UVB-irradiated
(100 mJ/cm2) keratinocytes. The addition of IGF-1 to growth
factor-deprived cells resulted in a strong increase of BAD in
the cytosolic fraction and a corresponding decrease of BAD
in the mitochondrial fraction (Figure 5a).
Because changes in BAD localization can also be
modified by 14-3-3 protein binding, co-immunoprecipita-
tion-Western blot analysis was performed on keratinocytes
treated with UVB in the presence or absence of IGF-1 or after
infection with myristylated AKT or EGFP. After UVB
irradiation, glutathione S-transferase (GST) pull-down assay
with GST-14-3-3z-interacting protein or with pGEX (control)
was performed on these keratinocytes. Phosphoproteins
bound to 14-3-3z were separated on SDS–PAGE and
analyzed for BAD phosphorylation, using the phospho-
specific antibody, phospho-BAD (Ser136). Figure 5b clearly
demonstrates an increase of AKT-specific Ser136 phospho-
BAD, bound to 14-3-3z, in the presence of IGF-1 or
membrane-targeted AKT in UVB-irradiated cells. In addition,
the binding of phospho-BAD (Ser136) to 14-3-3z after
wortmannin supplementation was also investigated using a
GST pull-down assay with GST-14-3-3z (Figure 5c) or pGEX
(data not shown). We show that the binding of pSer136BAD
to 14-3-3z is reduced when wortmannin, an irreversible
inhibitor of phosphatidylinositol 3-kinase, was added to
unirradiated or UVB-irradiated, IGF-1-supplemented cells
(Figure 5c). The reduction of phospho-BAD by wortmannin
was accompanied by a decrease of phospho-AKT (Ser473) to
a level similar to that of keratinocytes grown in growth factor-
deprived medium. The increase in phospho-BAD (Ser136),
bound to 14-3-3z in the presence of IGF-1 and of active AKT
was not only shown in cells irradiated with 100 mJ/cm2 UVB,
but also in cells irradiated with a low UVB dose (64 and
32 mJ/cm2), indicating that the proposed molecular mechan-
ism of early- versus late UVB-induced apoptosis is also
operable at more physiological UVB doses (Figure 5b).
DISCUSSION
We show that UVB-induced apoptosis in growth factor-
deprived primary human keratinocytes is mediated by
cytochrome c release and procaspase-9 cleavage, but not
by procaspase-8 or BID cleavage, indicating that this process
is exclusively triggered through the intrinsic, mitochondrial
pathway. Further confirmation on the involvement of the
intrinsic pathway of apoptosis was found by looking at the
activation status of the proapoptotic BCL-2 family member
BAX. In unstressed cells, BAX is sequestered in the cytosol in
an inactive conformation. Exposure of the N-terminus,
possibly by interaction with a BH3-only protein or through
an alternative activation mechanism, results in the transloca-
tion of BAX from the cytosol to the mitochondria, where it
inserts into the outer membrane and directly participates in
cytochrome c release (Cartron et al., 2003). Very recently, we
could show in human keratinocytes that activation of p38
mitogen-activated protein kinase by UVB represents a crucial
proapoptotic signal required for the conformational change
and translocation of BAX to the mitochondria (Van Laethem
et al., 2004). In agreement with a prominent role of p38
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Figure 5. A role for AKT-induced translocation of BAD in the delay of
early-activated apoptosis. (a) Growth factor-deprived primary human
keratinocytes were irradiated with 100 mJ/cm2 UVB. At the indicated time
points, mitochondrial and cytosolic fractions were isolated by subcellular
fractionation. Proteins were separated by SDS–PAGE and analyzed by
immunoblotting with anti-BAD antiserum. Where indicated, IGF-1 (10 ng/ml)
was added 30 minutes before UVB irradiation. (b) Forty-eight hours before
UVB irradiation, cultured growth factor-deprived keratinocytes were
transduced with adenoviral construct expressing EGFP (control) or
Ad.myrAKT-HA. Where indicated, IGF-1 (10 ng/ml) was supplemented
30 minutes before UVB irradiation. Cells were irradiated with 32, 64, or
100 mJ/cm2 UVB. Cells were harvested 1.5 hours after irradiation and a GST
pull-down assay with GST-14-3-3z-interacting protein was performed, as
described in ‘‘Materials and Methods’’. We also performed a negative control
with pGEX alone. Proteins were separated by SDS–PAGE and membranes
were incubated with the primary antibody phospho-BAD (Ser136). (c) Primary
human keratinocytes, cultured in growth factor-deprived medium, were
irradiated with 100 mJ/cm2 UVB. IGF-1 (10 ng/ml) was added half an hour
before UVB irradiation, and wortmannin (1 mM) was supplemented 30 minutes
before IGF-1 supplementation. Cells were harvested at the indicated time
point. A GST pull-down assay with GST-14-3-3z-interacting protein was
performed as described in ‘‘Materials and Methods’’ and analyzed by
immunoblotting with anti-phospho-BAD (Ser136) antiserum. Cell lysates
were also analyzed for pSer473AKT and actin to ensure equal protein loading.
A representative result of three independent experiments is shown.
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mitogen-activated protein kinase in the intrinsic pathway of
apoptosis, inhibition of p38 mitogen-activated protein kinase
strongly reduces UVB-induced formation of sunburn cells in
human skin. In this study, we show that, 3 hours after UVB
irradiation, growth factor-deprived cells stained positive for
the active, N-terminal end exposed, conformation of BAX.
Notably, IGF-1-supplemented cells did not. There are two
possible explanations for this observation. IGF-1 signaling
either directly inhibits the conformational activation of BAX,
leaving the N-terminal end inaccessible to the antibody. Or
in IGF-1-supplemented cells, activated BAX is bound to and
inhibited by the prosurvival BCL-2 family members BCL-2
and BCL-XL. Heterodimerization of BAX to BCL-2 and BCL-XL
blocks the binding of the N-terminal-specific antibodies to
BAX by steric hindrance (Hsu and Youle, 1997). Thus, in
UVB-irradiated human keratinocytes, both IGF-1/AKT and
p38 mitogen-activated protein kinase signaling pathways
seem to converge on BAX to exert their opposite function. In
addition, recent data of Yuan et al. (2003) suggest that AKT
inhibits cisplatin-induced p38 and BAX activation. Therefore,
it remains to be investigated whether IGF-1/AKT could inhibit
p38 mitogen-activated protein kinase in human UVB-
irradiated keratinocytes.
To determine if the downstream effector of IGF-1, AKT,
was able to mediate the delay of UVB-induced apoptosis, we
employed an adenoviral vector approach expressing AKT in a
membrane-targeted form (Ad.myrAKT-HA). We confirmed
that overexpression of membrane-targeted AKT was able to
postpone the UVB-induced apoptosis by several hours
(Figure 4), thus exactly mimicking the effect of IGF-1
supplementation, as shown in a previous study (Decraene
et al., 2002).
Next, we wanted to characterize the molecular target,
downstream of AKT, involved in the delay of early UVB-
induced apoptosis. It was clear that this downstream target of
AKT is involved in survival, must intervene in the intrinsic
activation of apoptosis in response to UVB, and executes its
prosurvival function in a transcription-independent way
(Figure 3). This pinpointed the BH3-only protein BAD as
one of the most likely candidates for AKT-mediated action.
BH3-only proteins (e.g. BAD, BIM, PUMA, NOXA, and BID)
have been recognized as essential initiators of apoptotic cell
death, with a central role in the induction of intrinsic
apoptosis (Huang and Strasser, 2000). They initiate this event
by disrupting the delicate balance that exists between pro-
(e.g. BAX and BAK) and antiapoptotic (e.g. BCL-2, BCL-XL,
and BCL-W) members of the BCL-2 family in favor of
apoptosis (Huang and Strasser, 2000). In contrast to many
BH3-only proteins, BAD does not seem to have a direct
ability to induce the release of cytochrome c from the
mitochondria. It does however sequester BCL-2 and BCL-XL
away from BAX-like proteins, thereby neutralizing their
protective effect (Yang et al., 1995).
The observation that BAD, when phosphorylated by AKT,
raises the threshold at which mitochondria release cyto-
chrome c in response to apoptotic stimuli (Datta et al., 2002),
greatly substantiated the probability that BAD phosphoryla-
tion is responsible for the IGF-1-mediated delay of apoptosis
in UVB-irradiated keratinocytes. The activity of BAD is
directly regulated by the AKT kinase. BAD is phosphorylated
by AKT at the Ser136 site (Datta et al., 1997). The
phosphorylation of BAD at Ser136 triggers its recruitment to
cytosolic 14-3-3 proteins, which disrupts the ability of BAD
to interact with BCL-2 and BCL-XL by forcing it to abandon its
mitochondrial localization (Datta et al., 2000). In this study,
we show that in human keratinocytes, the overexpression of
membrane-targeted AKT results in BAD Ser136 phosphoryla-
tion after UVB irradiation (Figure 4). Moreover, translocation
of BAD from the mitochondria to the cytosol is indeed also
observed when endogenous AKT is activated by IGF-1 (Figure
5a). In full accordance with this, IGF-1-treated keratinocytes
or keratinocytes overexpressing the membrane-targeted AKT
demonstrate an increase in Ser136 phospho-BAD, bound to
14-3-3z. In addition, IGF-1-induced increase of Ser136
phospho-BAD bound to 14-3-3z was reduced, when wort-
mannin, an irreversible inhibitor of phosphatidylinositol 3-
kinase, was added before IGF-1 supplementation (Figure 5c).
This result shows that the final outcome of AKT phosphoryla-
tion, the binding of Ser136 phospho-BAD to 14-3-3z, can be
reduced by inhibiting the IGF-1/phosphatidylinositol 3-kinase
cascade. We also show that UVB itself has the possibility to
cause a small increase of AKT-specific Ser136 phospho-BAD,
bound to 14-3-3z (Figure 5b). However, this increase is
insufficient to prevent early-induced apoptosis in growth
factor-depleted medium, whereas supplementation of IGF-1
or infection with Ad.myrAKT-HA, which cause a significantly
further increase in the amount of phosphorylated BAD bound
to 14-3-3z, is able to postpone UVB-induced apoptosis. This
indicates that UV can activate both anti- (Wang et al., 2003)
and proapoptotic pathways. However, the final destination of
keratinocytes (apoptosis versus survival) after UV will depend
on the balance between the activation of pro- and
antiapoptotic pathways.
A forced cytoplasmic localization of BAD by AKT explains
why, 3 hours after UVB irradiation, IGF-1-supplemented cells
did not stain positive for the active conformation of BAX
(Figure 1l) whereas IGF-1-deprived did (Figure 1i). In the
absence of mitochondrial BAD, BCL-XL and BCL-2 are free to
bind BAX. Hsu and Youle (1997) reported that steric
hindrance caused by this heterodimerization with BCL-XL
or BCL-2 makes BAX inaccessible to N-terminal-directed
antibodies.
In human skin cells, exposed to UVB-irradiation, two
waves of apoptosis can be discerned; one that occurs within
the first 3 hours after UVB-irradiation and one that occurs
several hours later (Decraene et al., 2002). Our data indicate
that the BH3-only protein BAD functions as a molecular, IGF-
1-sensitive switch in keratinocytes, a switch which deter-
mines the choice between early- and late-activated apoptosis
in response to UVB damage. As these findings were
demonstrated in primary keratinocytes derived from normal
human skin and as the molecular events regulating early
UVB-induced apoptosis and its delay were also operable at a
physiological UVB dose, corresponding to a moderate to
severe sunburn in human skin in vivo, we provide a model for
the IGF-1/AKT-induced modulation of the apoptotic response
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of human skin to UVB by which IGF-1/AKT signaling
increases survival in UVB-irradiated keratinocytes (Figure 6).
In addition to the physiological role of AKT in human
keratinocytes and skin, the AKT pathway has been increas-
ingly documented as a prime determinant of tumor promo-
tion and progression in several cell types, including
keratinocytes (Segrelles et al., 2002). Previously, we con-
ducted a study on two squamous-cell carcinoma-derived cell
lines (A253 and A431) which revealed a deregulated
apoptotic response to UVB, concomitant with an altered
phosphorylation status of AKT in these malignant cells
(Decraene et al., 2004). Our previous data suggest that in
addition to p53, the most frequently mutated gene in UV-
induced squamous-cell carcinoma of the skin (Brash et al.,
1996), deregulated AKT signaling may also play a role in the
photocarcinogenic process of the skin, and that agents that
target the AKT pathway may have a therapeutic effect in UV-
induced skin cancer. This statement is further supported by
the fact that a protein kinase inhibitor targeting the AKT
survival pathway is currently in phase I trial for head and
neck squamous-cell carcinoma (Kondapalli et al., 2005).
Our data provide, to our knowledge, for the first time a
molecular mechanism for the delay of early UVB-induced
apoptosis. They reveal an important physiological example of
the role of AKT and BAD phosphorylation in IGF-1-induced
delay of UVB-induced apoptosis in normal human keratino-
cytes. It has become clear that the level of IGF-1/AKT
signaling, next to the important role of p53, is a key factor
in the response of human skin to solar UVB irradiation,
a role that should be considered in the development of
effective therapeutic strategies in the treatment of
UV-induced skin cancer.
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Figure 6. Model for the IGF-1/AKT-induced modulation of the apoptotic response of keratinocytes to UVB. In the absence of IGF-1 signaling, BAD is
localized at the mitochondria, where it binds and inhibits the antiapoptotic BCL-2 family members BCL-XL and BCL-2. Following UVB-induced BAX
mitochondrial translocation, most likely mediated through interaction with an up to now unidentified BH3-only protein, BAX and BAK are able to
cooperate freely and permeabilize the now more vulnerable mitochondria, resulting in the leakage of cytochrome c and the subsequent activation of
intrinsic apoptosis. In the event of IGF-1/AKT signaling, BAD is phosphorylated at Ser136 and is recruited by cytosolic 14-3-3z proteins. The subsequent
release of BCL-XL and BCL-2 directly interferes with BAX/BAK-induced mitochondrial permeabilization. This increases the threshold of apoptotic stimuli
required to release cytochrome c and as a result postpones the induction of apoptosis by several hours. At moderate UVB-damage levels, the acquired extra
time for DNA repair could toggle the decision between survival and apoptosis in favor of survival. GF: Growth factor-deprived keratinocytes; IGF-1:
IGF-1-supplemented keratinocytes; and Ad.myrAKT-HA: keratinocytes transduced with membrane-targeted AKT.
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MATERIALS AND METHODS
Reagents and antibodies
Monoclonal anti-human PARP antibody, mouse anti-cytochrome c,
mouse anti-caspase-8, and polyclonal rabbit anti-mouse IkB-a
antibodies were purchased from BD Biosciences (Belgium). N-
terminal BAX antibody, recognizing the active conformation of BAX
was from Upstate Biotechnology (Lake Placid, NY). Polyclonal anti-
AKT, polyclonal phospho-AKT (Thr308), and rabbit anti-caspase-9
antibodies were from Cell Signaling (Beverly, MA) and polyclonal
anti-pSer473AKT was purchased from Promega, The Netherlands.
Phospho-BAD (Ser136) antibody was from Santa Cruz Biotechno-
logy (Santa Cruz, CA). Rabbit anti-BAD and goat anti-BID were
purchased from R&D Systems (Minneapolis, MN). The monoclonal
actin antibody was obtained from the Developmental Studies
Hybridoma Bank (University of Iowa). Cycloheximide, IGF-1, and
wortmannin were purchased from Sigma-Aldrich (Belgium). Mito-
TrackerRed CMXRos was from Molecular Probes (Eugene, OR).
Cell culture and UVB irradiation
Primary human keratinocytes were isolated and pooled from
foreskins of five different donors (less than 6 years) as described
(Gilchrest, 1983). Third to fifth passage cells were used in
experiments. The procedure has been approved by the ethical
committee of the University of Leuven. Experiments performed
adhered to the Declaration of Helsinki Principles.
Keratinocytes were initially seeded in serum-free and growth
factor-containing medium (Keratinocyte-SFM; Invitrogen, Belgium),
which harbors several growth factors (5 mg/ml insulin, 74 ng/ml
hydrocortisone, 6.7 ng/ml triiodo-L-thyronine, 50 mg/ml bovine pitui-
tary extract, and 5 ng/ml human recombinant EGF). When they
reached 40% confluency, cells were washed twice with phosphate-
buffered saline (PBS) and incubated for 48 hours with serum-free
Keratinocyte Basal Medium (Cambrex Bioproducts, Belgium),
deficient in the above-stated growth factors. Where indicated, pre-
incubation with IGF-1 (10 ng/ml; Sigma-Aldrich, Belgium) was
performed 30 minutes before UVB irradiation and wortmannin
(1mM) was supplemented 30 minutes before IGF-1 supplementation.
Before UVB irradiation, cells were washed twice with PBS, were
then irradiated through a thin film of PBS, and re-fed with their own
medium. Cells were exposed through the cover of the dish, which
filters out residual UVC (Brown et al., 2001). The UVB source was a
parallel bank of two Philips TL 20W12 tubes with a peak output
around 310 nm. Output was measured with an IL700 radiometer
(International light, Newburyport, MA).
Adenoviral vectors
Recombinant adenovirus constructs were generated by using
the AdEasy system (Q-Biogene, France) with pAdTrack-cytomegalo-
virus as a transfer vector. AdTrack viral vector expresses the
indicated protein and EGFP, both under the control of the
cytomegalovirus promoter. For the construction of adenovirus
constructs expressing EGFP, only pAdTrack-cytomegalovirus and
pAdEasy-1 were recombined in bacteria. Adenoviral constructs were
amplified in 293 cells and purified by cesium chloride gradient
centrifugation. Particle count was estimated from OD260. Stock titer
was E1010 plaque-forming unit/ml. Ad.myrAKT-HA was kindly
provided by Dr Anthony Rosenzweig (Massachusetts General
Hospital, Boston, MA).
Western blot analysis
For the analysis of procaspase-9 cleavage, keratinocytes were
harvested in Chaps Cell Extract Buffer as described by the
manufacturer (Cell Signaling, Beverly, MA). For all other experi-
ments, cells were scraped in lysis buffer (25 mM N-2-hydroxyethyl-
piperazine-N0-2-ethanesulfonic acid, 0.3 mM NaCl, 1.5 mM MgCl2,
20 mM b–glycerolphosphate, 2 mM EDTA, and 2 mM EGTA (pH 7.5))
containing 1% Triton, 10% glycerol, 1 mM Na3VO4, 0.5 mM
dithiothreitol, 10 mg/ml Leupeptin, 10 mg/ml Aprotinin, and 10mg/
ml Antipain. Extracts were incubated on ice and spun down at
14,000 r.p.m. for 20 minutes. Protein concentration was determined
using the BCA Protein Assay Reagent (Pierce Chemical Company,
Rockford, IL). Fifty to 80 mg of total protein extract was separated by
a 10% SDS–PAGE, followed by wet electrotransfer onto Hybond-C
Super membrane (Amersham Pharmacia Biotech, Piscataway, NJ).
Equal loading of proteins was verified using Ponceau-S. Membranes
were blocked for 1 hour at room temperature in Tris-buffered saline
containing 0.1% Tween-20 and 5% non-fat dry milk. The membrane
was incubated overnight at 41C with the primary antibody, washed,
and incubated for 1 hour at room temperature with the peroxidase-
conjugated secondary antibody. Protein bands were visualized using
enhanced chemiluminescence as described by the supplier (Amer-
sham Pharmacia Biotech, Piscataway, NJ).
Immunocytochemistry
For immunostaining experiments, cells were cultured in one-well
Chamberslides (Nalge Nunc International, Naperville, IL). At the
indicated time points, cells were fixed in 10% paraformaldehyde for
30 minutes, followed by a 10 minutes permeabilization with PBS
containing 0.1% SDS. Cells were blocked for 20 minutes at room
temperature in blocking buffer (PBS, 3% BSA, and 0.1% Tween-20),
incubated in blocking buffer containing the primary antibody for
1 hour at room temperature, rinsed five times in PBS, followed by
incubation in blocking buffer containing an Alexa Fluor 488
secondary antibody conjugate (Molecular Probes, The Netherlands).
MitoTrackerRedCMXRos was added at a concentration of 50 nM
1 hour before fixation. After a final rinse in PBS, cells were viewed
under a fluorescence microscope.
GST fusion protein purification
pGEX-GST-14-3-3z construct was overexpressed in E. coli BL21 cells
by induction with 0.4 mM isopropyl-b-D-thiogalactopyranoside. After
sonication, the obtained lysates were centrifuged and purified by
binding to gluthatione sepharose 4B beads (Amersham Pharamacia
Biotech, Piscataway, NJ). Purified proteins were eluted from the
beads with 10 mM gluthatione and 45 mM Tris-HCl (pH 8).
GST pull-down assay
Cells were harvested at the indicated time points after UVB in lysis
buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM
EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerophosphate, 1 mM Na3VO4, and 1mg/ml Leupeptin. Two
hundred micrograms of protein lysate was put together with 30mg of
purified eluate to rotate overnight at 41C. The lysates were mixed
with 15 mg of gluthatione sepharose 4B beads and incubated for
another 24 hours at 41C. Following several washes with lysis buffer,
30 ml 1 SDS loading buffer (50 mM Tris-HCl (pH 6.8), 2% SDS, 6%
glycerol, and 0.002% bromophenol blue) was added and the
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samples were heated at 991C to release bound protein. Proteins
were subsequently separated on SDS–PAGE and analyzed for
Western blot.
Subcellular fractionation
At different time points, cells were scraped in isotonic lysis buffer
(20 mM N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid,
250 mM sucrose, 10 mM KCl, 1.5 mM. MgCl2, 1 mM EGTA, 1 mM
dithiothreitol, 10 mg/ml Leupeptin, 10 mg/ml Aprotinin, and 10 mg/ml
Antipain). Following 15 minutes incubation on ice, cells were
homogenized with a douncer and subjected to differential centrifu-
gation. Nuclei and unbroken cells were pelleted three times by
centrifugation at 1,300 g and discarded. The supernatant was
centrifuged at 17,000 g for 15 minutes. The pellet (mitochondrial
fraction) was resuspended in isotonic lysis buffer containing 1%
IGEPAL, and the supernatant was exposed to a final centrifugation
step (40 minutes at 55,000 g). Following this final centrifugation step,
the pellet (light membrane fraction) was discarded. The supernatant
represents the cytosolic fraction. Lysates (mitochondrial and
cytosolic fractions) were then subjected to Western blot analysis as
described above.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Dr A. Rosenzweig for the kind donation of the adenoviral
construct expressing the membrane-targeted form of AKT (Ad.myrAKT-HA)
and Dr K.D. Bloch for the critical reading of the manuscript. We thank
the Developmental Studies Hybridoma Bank for the monoclonal actin
antibody. This article was supported by Grant 0211.99 from the ‘‘Fonds voor
Wetenschappelijk Onderzoek–Vlaanderen’’ and Grant OT/04/42 from the
University of Leuven.
REFERENCES
Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P et al.
(1996) Mechanism of activation of protein kinase B by insulin and IGF-1.
EMBO J 15:6541–51
Assefa Z, Van Laethem A, Garmyn M, Agostinis P (2005) Ultraviolet radiation-
induced apoptosis in keratinocytes: on the role of cytosolic factors.
Biochim Biophys Acta 1755:90–106
Bellacosa A, Testa JR, Staal SP, Tsichlis PN (1991) A retroviral oncogene, akt,
encoding a serine-threonine kinase containing an SH2-like region.
Science 254:274–7
Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ (1996)
Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor
promotion. J Investig Dermatol Symp Proc 1:136–42
Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA (1997)
Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the
cell cycle regulator E2F. Immunity 7:679–89
Brown DB, Peritz AE, Uitto J, Gasparro FP (2001) Ultraviolet-filtering
properties of commonly used tissue cell culture plasticware. Photo-
dermatol Photoimmunol Photomed 17:126–9
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999) Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell 96:857–68
Capano M, Crompton M (2002) Biphasic translocation of Bax to mitochon-
dria. Biochem J 367:169–78
Cartron PF, Priault M, Oliver L, Meflah K, Manon S, Vallette FM (2003) The
N-terminal end of Bax contains a mitochondrial-targeting signal. J Biol
Chem 278:11633–41
Claerhout S, Van Laethem A, Agostinis P, Garmyn M (2006) Pathways
involved in sunburn cell formation: deregulation in skin cancer.
Photochem Photobiol Sci 5:199–207
Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell
116:205–19
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y et al. (1997) Akt
phosphorylation of BAD couples survival signals to the cell-intrinsic
death machinery. Cell 91:231–41
Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB et al. (2000) 14–3–3
proteins and survival kinases cooperate to inactivate BAD by BH3
domain phosphorylation. Mol Cell 6:41–51
Datta SR, Ranger AM, Lin MZ, Sturgill JF, Ma YC, Cowan CW et al. (2002)
Survival factor-mediated BAD phosphorylation raises the mitochondrial
threshold for apoptosis. Dev Cell 3:631–43
Decraene D, Agostinis P, Bouillon R, Degreef H, Garmyn M (2002) Insulin-
like growth factor-1-mediated AKT activation postpones the onset of
ultraviolet B-induced apoptosis, providing more time for cyclobutane
thymine dimer removal in primary human keratinocytes. J Biol Chem
277:32587–95
Decraene D, Van Laethem A, Agostinis P, De Peuter L, Degreef H, Bouillon R
et al. (2004) AKT status controls susceptibility of malignant keratinocytes
to the early-activated and UVB-induced apoptotic pathway. J Invest
Dermatol 123:207–12
DiGiovanni J, Bol DK, Wilker E, Beltran L, Carbajal S, Moats S et al. (2000)
Constitutive expression of insulin-like growth factor-1 in epidermal basal
cells of transgenic mice leads to spontaneous tumor promotion. Cancer
Res 60:1561–70
Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM et al. (1997)
Regulation of neuronal survival by the serine-threonine protein kinase
Akt. Science 275:661–5
Gilchrest BA (1983) In vitro assessment of keratinocyte aging. J Invest
Dermatol 81:184s–9s
Henriksen T, Dahlback A, Larsen SH, Moan J (1990) Ultraviolet-radiation and
skin cancer. Effect of an ozone layer depletion. Photochem Photobiol
51:579–82
Hsu YT, Youle RJ (1997) Nonionic detergents induce dimerization among
members of the BCL-2 family. J Biol Chem 272:13829–34
Huang DC, Strasser A (2000) BH3-Only proteins-essential initiators of
apoptotic cell death. Cell 103:839–42
Jaattela M (1999) Escaping cell death: survival proteins in cancer. Exp Cell Res
248:30–43
Kim AH, Khursigara G, Sun X, Franke TF, Chao MV (2001) Akt phosphorylates
and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell
Biol 21:893–901
Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B et al. (2002) Akt1
regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35:697–709
Kondapalli L, Soltani K, Lacouture ME (2005) The promise of molecular
targeted therapies: protein kinase inhibitors in the treatment of cutaneous
malignancies. J Am Acad Dermatol 53:291–302
Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM
(1999) Direct control of the Forkhead transcription factor AFX by protein
kinase B. Nature 398:630–4
Kulik G, Klippel A, Weber MJ (1997) Antiapoptotic signalling by the insulin-
like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol
Cell Biol 17:1595–606
Kulms D, Schwarz T (2002) Independent contribution of three different
pathways to ultraviolet-B-induced apoptosis. Biochem Pharmacol
64:837–41
Leri A, Liu Y, Claudio PP, Kajstura J, Wang X, Wang S et al. (1999) Insulin-like
growth factor-1 induces Mdm2 and down-regulates p53, attenuating the
myocyte renin–angiotensin system and stretch-mediated apoptosis. Am J
Pathol 154:567–80
Matsui T, Li L, del Monte F, Fukui Y, Franke TF, Hajjar RJ et al. (1999)
Adenoviral gene transfer of activated phosphatidylinositol 30-kinase and
Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation
100:2373–9
www.jidonline.org 437
S Claerhout et al.
AKT Delays the Early Apoptotic UVB Response
Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN,
Rosen N (1998) Cyclin D expression is controlled post-transcriptionally
via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem
273:29864–72
Okumura E, Fukuhara T, Yoshida H, Hanada Si S, Kozutsumi R, Mori M et al.
(2002) Akt inhibits Myt1 in the signalling pathway that leads to meiotic
G2/M-phase transition. Nat Cell Biol 4:111–6
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-
kappaB activation by tumour necrosis factor requires the Akt serine-
threonine kinase. Nature 401:82–5
Remacle-Bonnet MM, Garrouste FL, Heller S, Andre F, Marvaldi JL,
Pommier GJ (2000) Insulin-like growth factor-I protects colon
cancer cells from death factor-induced apoptosis by potentiating
tumor necrosis factor alpha-induced mitogen-activated protein
kinase and nuclear factor kappaB signaling pathways. Cancer Res 60:
2007–17
Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova IV et al. (2002)
Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene
21:53–64
Van Laethem A, Claerhout S, Garmyn M, Agostinis P (2005) The sunburn cell:
regulation of death and survival of the keratinocyte. Int J Biochem Cell
Biol 37:1547–53
Van Laethem A, Van Kelst S, Lippens S, Declercq W, Vandenabeele P,
Janssens S et al. (2004) Activation of p38 MAPK is required for Bax
translocation to mitochondria, cytochrome c release and apoptosis
induced by UVB irradiation in human keratinocytes. FASEB J 18:1946–8
Wang HQ, Quan T, He T, Franke TF, Voorhees JJ, Fisher GJ (2003) Epidermal
growth factor receptor-dependent, NF-kappaB-independent activation of
the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irra-
diation-induced caspases-3, -8, and -9 in human keratinocytes. J Biol
Chem 278:45737–45
Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ (1995) Bad, a
heterodimeric partner for Bcl-XL and BCL-2, displaces Bax and promotes
cell death. Cell 80:285–91
Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV, Cheng JQ (2003)
AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by
phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol
Chem 278:23432–40
Zheng WH, Kar S, Quirion R (2000) Insulin-like growth factor-1-induced
phosphorylation of the forkhead family transcription factor FKHRL1 is
mediated by Akt kinase in PC12 cells. J Biol Chem 275:39152–8
Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC (2001) Cytoplasmic
localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-
2/neu-overexpressing cells. Nat Cell Biol 3:245–52
438 Journal of Investigative Dermatology (2007), Volume 127
S Claerhout et al.
AKT Delays the Early Apoptotic UVB Response
